Analysts Staying On The Sidelines On Cree Until Sales Return To 20% Growth

By: via Benzinga
UBS said in a research note that it's keeping a Sell rating on the shares of Cree, Inc. (NASDAQ: CREE) until total sales growth returns ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.